How big is the Intravenous Iron Drugs Market?

The Intravenous Iron Drugs Market size is expected to reach USD 3.05 billion in 2024 and grow at a CAGR of 8.5% to reach USD 4.58 billion by 2029. Read More

What is the current Intravenous Iron Drugs Market size?

In 2024, the Intravenous Iron Drugs Market size is expected to reach USD 3.05 billion. Read More

Who are the key players in Intravenous Iron Drugs Market?

Sanofi, Pharmocosmos, AbbVie (Allergan), Covis Pharma GmbH (AMAG Pharmaceuticals, Inc) and CSL Limited (Vifor Pharma Management Ltd.) are the major companies operating in the Intravenous Iron Drugs Market. Read More

Which is the fastest growing region in Intravenous Iron Drugs Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Intravenous Iron Drugs Market?

In 2024, the North America accounts for the largest market share in Intravenous Iron Drugs Market. Read More

What years does this Intravenous Iron Drugs Market cover, and what was the market size in 2023?

In 2023, the Intravenous Iron Drugs Market size was estimated at USD 2.79 billion. The report covers the Intravenous Iron Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Intravenous Iron Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Intravenous Iron Drugs Market Share

Statistics for the 2023 & 2024 Intravenous Iron Drugs market share, created by Mordor Intelligence™ Industry Reports. Intravenous Iron Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Intravenous Iron Drugs Industry

The intravenous iron drugs market is consolidated and consists of a few players across the globe. In terms of market share, a few of the major players are currently dominating the market. Some of the companies that hold a significant market share are CSL Limited (Vifor Pharma Management Ltd.), AbbVie (Allergan), Covis Pharma GmbH (AMAG Pharmaceuticals, Inc), Sanofi, Pharmocos, Shield Therapeutics Rockwell Medical, American Regent among others.